Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:15am, Tuesday, 24'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Geron (GERN
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application ...
12:00am, Friday, 20'th Mar 2020The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, JELD and CRON
04:30pm, Thursday, 19'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 19, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.
CLASS ACTION UPDATE for GERN, CCI and ALGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
02:45pm, Tuesday, 17'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 17, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholder
B. Riley FBR Maintains Buy on Geron, Lowers Price Target to $3.5
12:00am, Tuesday, 17'th Mar 2020HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 8 Days ...
12:00am, Sunday, 15'th Mar 2020Geron (GERN) Gets a Buy Rating from Needham
09:24am, Friday, 13'th Mar 2020
Needham analyst Chad Messer reiterated a Buy rating on Geron (GERN) today and set a price target of $3.00. The company's shares closed last Monday at
Geron (GERN) Gets a Buy Rating from Needham
09:23am, Friday, 13'th Mar 2020
Needham analyst
Chad Messer
reiterated a
Buy
rating on Geron (
GERN
–
Research Report
) today and set a price target of
$3.00
. The company’s shares closed last Monday at $0.99, close to its 52-we
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of QD, GERN and JELD
03:00pm, Wednesday, 11'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 11, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to partici
SHAREHOLDER ALERT: GERN JELD CCI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
02:50pm, Tuesday, 10'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 10, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
